|
NATEXVIR
30 Nov 2022
Wording : Implementation and validation of techniques and methods for the preparation of bioactive natural extracts with a view to their valuation as a therapeutic solution against human respiratory viruses.
Duration : 24 months - from December 2022 to November 2024
Type : Win4Collective
Budget : €355,653.60 financed at 75%.
| |
|
|
|
|
